In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years.

A rival re-emerges, investors brace for impact and the Ozempic scare dissolves. ResMed’s growth story just got more interesting. ... Read More The post Dr Boreham’s Crucible: A rival may be circling, ...

AMSTERDAM – In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years. During a ...

Respiratory Care Devices Market Report, published by Allied Market Research, suggests that the global respiratory care ...

Philips is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of healthcare, consumer lifestyle and lighting. Philips makes ...